Szívelégtelenség: nyitott vizsgálatok itt: Dél-Korea

In Dél-Korea 56 Also abroad 1261

56 trials · From ClinicalTrials.gov, checked 2026. nov. 10.. Ask the study team whether a trial fits you.

No phaseToborozResearch participation
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Where
Busan, Cheongju-si, Daegu, Daejeon, Gwangju, Gyeonggi-do, Jeonju, Seongnam-si, Seoul, Suwon, Yangsan
People
20 000 worldwide
Run by
Medtronic
See details and how to joinNCT00271180Regiszter frissítve: 2026-11-04
2/3. fázisToborozTrial-stage medicine
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Where
Pusan, Seoul
Age
29 nap to 17 év
People
342 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT05714085EU 2022-501238-52-00Regiszter frissítve: 2026-10-30
No phaseToborozResearch participation
AI-Based Cardiac Analysis Using 12-Lead and 1-Lead ECG
Where
Incheon
Age
19 év and over
People
300
Run by
Inha University Hospital
See details and how to joinNCT07844434Regiszter frissítve: 2026-10-30
3. fázisToborozTrial-stage medicine
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Where
Daejeon, Gwangju, Seongnam-si, Gyeonggi-do, Seoul, Wonju-si, Gangwon-do
Age
18 év to 99 év
People
5056 worldwide
Run by
Amgen
See details and how to joinNCT07037459Regiszter frissítve: 2026-10-29
3. fázisToborozTrial-stage medicine
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Where
Bucheon-si, Busan, Cheongju-si, Daegu, Daejeon, Deagu, Gwangju, Incheon, Seongnam, Seoul, Wonju-si, Gangwon State, Yangsan
Age
18 év and over
People
6712 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06424288EU 2023-509706-30-00Regiszter frissítve: 2026-10-28
3. fázisToborozTrial-stage medicine
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Where
Busan, Gwangju, Incheon, Seongnam, Seoul, Wŏnju
Age
18 év and over
People
4200 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06935370EU 2024-519525-38-00Regiszter frissítve: 2026-10-28
3. fázisToborozTrial-stage medicine
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Where
Seoul, Yangsan
Age
Up to 18 év
People
117 worldwide
Run by
Bayer
See details and how to joinNCT07192952EU 2024-519830-22-00Regiszter frissítve: 2026-10-27
No phaseToborozResearch participation
Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support
Where
Changwon, Incheon, Seoul
Age
19 év and over
People
500
Run by
Samsung Medical Center
See details and how to joinNCT07482865Regiszter frissítve: 2026-10-23
3. fázisToborozTrial-stage medicine
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Where
Bucheon-si, Cheongju-si, Daegu, Seongnam-si, Seoul, Suwon, Wŏnju, Yangsan
Age
40 év and over
People
11 300 worldwide
Run by
AstraZeneca
See details and how to joinNCT06677060EU 2024-514506-32-00Regiszter frissítve: 2026-10-21
3. fázisToborozTrial-stage medicine
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Where
Busan, Seongnam-si, Seoul
Age
18 év and over
People
1280 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07207811Regiszter frissítve: 2026-10-21
3. fázisToborozTrial-stage medicine
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Where
Jongno, Seodaemun, Seoul, Yangsan
Age
6 hónap to 17 év
People
111 worldwide
Run by
Bayer
See details and how to joinNCT07188805EU 2024-519829-38-00Regiszter frissítve: 2026-10-15
3. fázisToborozResearch participation
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Where
Anyang-si, Bucheon-si, Busan, Cheongju-si, Daegu, Daejeon, Gwangju, Gwangmyeong, Incheon, Junggu, Seongnam-si, Seoul, Uijeongbu-si, Wŏnju, Yangsan
Age
18 év to 130 év
People
3850 worldwide
Run by
AstraZeneca
See details and how to joinNCT06307652EU 2023-508162-15-00Regiszter frissítve: 2026-10-13
1. fázisToborozTrial-stage medicine
A Phase I Study of Allogeneic Myocardium-Derived Mesenchymal Stem Cells (HB1011) in Patients With Ischemic Cardiomyopathy
Where
Seongnam-si
Age
19 év to 85 év
People
12
Run by
HieraBio Inc.
See details and how to joinNCT07861035Regiszter frissítve: 2026-10-06
2. fázisToborozTrial-stage medicine
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Where
Cheongju-si, Daegu, Gangwon-do, Seongnam-si, Gyeonggi-do, Seoul
Age
40 év to 84 év
People
200 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06979362EU 2024-515796-35-00Regiszter frissítve: 2026-10-05
No phaseToborozResearch participation
AI-Powered Electrocardiography for Diagnosis and Prognostic Prediction in Cardiovascular Disease (AI-CVD): Multicenter Retrospective Study
Where
Incheon
Age
18 év and over
People
10 000
Run by
Inha University Hospital
See details and how to joinNCT07856472Regiszter frissítve: 2026-10-02
3. fázisToborozTrial-stage medicine
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Where
Busan, Daegu, Daejeon, Gwangju, Gyeonggi-do, Incheon, Seongbuk-Gu, Seoul, Suwon, Uijeongbu-si, Yangsan
Age
18 év and over
People
6950 worldwide
Run by
AstraZeneca
See details and how to joinNCT07761117EU 2026-526304-79-00Regiszter frissítve: 2026-09-28
3. fázisToborozTrial-stage medicine
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Where
Bucheon-si, Busan, Cheongju-si, Daegu, Daejeon, Gangneung, Gwangju, Incheon, Seoul, Wŏnju
Age
18 év and over
People
5200 worldwide
Run by
Colorado Prevention Center
See details and how to joinNCT06008197Regiszter frissítve: 2026-09-10
No phaseToborozResearch participation
Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation
Where
Seoul
Age
18 év and over
People
400 worldwide
Run by
Oslo University Hospital
See details and how to joinNCT07436299Regiszter frissítve: 2026-09-10
4. fázisToborozTrial-stage medicine
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study
Where
Daegu, Seongnam-si, Seoul, Suwon
Age
18 év and over
People
80
Run by
Kyungsub Song
See details and how to joinNCT07572032Regiszter frissítve: 2026-09-02
4. fázisToborozTrial-stage medicine
STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure
Where
Daegu, Seongnam-si, Seoul, Suwon, Yangsan
Age
19 év and over
People
80
Run by
Kyungsub Song
See details and how to joinNCT07631156Regiszter frissítve: 2026-09-02
4. fázisToborozTrial-stage medicine
Clinical Impact of SGLT2 Inhibitor After DC Cardioversion in Persistent AF With HFpEF
Where
Seoul
Age
19 év and over
People
200
Run by
Samsung Medical Center
See details and how to joinNCT07776054Regiszter frissítve: 2026-08-20
3. fázisToborozTrial-stage medicine
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Where
Anyang-si, Daegu, Daejeon, Gwangju, Incheon, Seongnam-si, Seoul, Suwon, Uijeongbu-si, Wŏnju, Yangsan
Age
18 év and over
People
5610 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07567001EU 2025-523717-29-00Regiszter frissítve: 2026-08-18
No phaseToborzás még nem indultResearch participation
Cardioprotective Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Korean Patients With Type 2 Diabetes
Where
Hwaseong-si
Age
19 év and over
People
100
Run by
Dongtan Sacred Heart Hospital
See details and how to joinNCT07770737Regiszter frissítve: 2026-08-18
No phaseToborozResearch participation
AI ECG Algorithm for Detecting LV Systolic Dysfunction
Where
Suwon
Age
19 év and over
People
1500
Run by
Ajou University School of Medicine
See details and how to joinNCT07636759Regiszter frissítve: 2026-08-07
No phaseToborozResearch participation
Early Detection and IntervenTion in Heart Failure
Where
Seoul
Age
65 év and over
People
18 000 worldwide
Run by
University Hospital, Basel, Switzerland
See details and how to joinNCT07731490Regiszter frissítve: 2026-07-28

Minden vizsgálat (Szívelégtelenség) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek